Drugs / Xiao-Xian-Gui-Fu-Tang
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04686955 | Jan 2021 → Dec 2022 | atopic eczema | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiao-Xian-Gui-Fu-Tang | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04686955 ↗ |
| Known as | VGH4 | “The Xiao-Xian-Gui-Fu-Tang (VGH4) includes Xiao-Feng-San 2.0g, Dang-Gui-Yin-Zi 1.2g, Bai-Xian-Pi (Cortex Dictamni Radicis) 0.4g, and Di-Fu-Zi (Fructus Kochiae) 0.5g.” NCT04686955 ↗ |